Firebird Diagnostics LLC

FireFlex-CoVary-19^TM

Home
Product Pipeline
FireFlex-CoVary-19^TM

FireFlex-CoVary-19^TM

Expands on FireFlex-COVID^TM to incorporate evolving coronaviruses

Exploits robust SAMRS and AEGIS technologies
Detects all key variants, including those that may evade vaccines (South Africa, UK, Brazil, others)
Firebird’s technology allows kit to be expanded as new mutants emerge

FireFlex-CoVary

Performance

Samples: nasal and nasopharyngeal swabs, saliva
Sensitivity: < 200 copies of virus per mL
Equipment: most 4-channel PCR instruments
Sample preparation: From saliva, none
Targets- COVID-19 variants, including UK, South Africa, Brazil
Flexibly expandable to include new variants as the emerge
Signal generation: < 90 minutes

Commercial

Firebird makes primers/probes
Firebird ships these worldwide for local assembly
Enzymes can be sourced locally or from Firebird
Partnerships sought worldwide

Technology & Publications

Powered by SAMRS^TM chemistry
Powered by AEGIS^TM chemistry

Yang & Benner (2020) Compositions for the Multiplexed Detection of Viruses. US Patent Appl. No. 17101467

Related Products

An new test in our family of FireFlex^TM products. See also: